Early-onset cardiac dysfunction following allogeneic haematopoietic stem cell transplantation
Open Heart
MAY 20, 2022
Objective Heart failure following allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a serious complication that requires early detection; however, the clinical implications of early-onset cancer therapy-related cardiac dysfunction (CTRCD) following allo-HSCT remain unclear. We investigated the determinants and prognostic impact of early-onset CTRCD in allo-HSCT recipients.
Let's personalize your content